1
|
Venables JP, Klinck R, Koh C, Gervais-Bird
J, Bramard A, Inkel L, Durand M, Couture S, Froehlich U, Lapointe
E, et al: Cancer-associated regulation of alternative splicing. Nat
Struct Mol Biol. 16:670–676. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chen J and Weiss WA: Alternative splicing
in cancer: Implications for biology and therapy. Oncogene. 34:1–14.
2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ishunina TA and Swaab DF: Estrogen
receptor-alpha splice variants in the human brain. Gynecol
Endocrinol. 24:93–98. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Dunnwald LK, Rossing MA and Li CI: Hormone
receptor status, tumor characteristics, and prognosis: A
prospective cohort of breast cancer patients. Breast Cancer Res.
9:R62007. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Goldhirsch A, Glick JH, Gelber RD, Coates
AS, Thürlimann B and Senn HJ Panel members: Meeting highlights:
International expert consensus on the primary therapy of early
breast cancer 2005. Ann Oncol. 16:1569–1583. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Huang B, Warner M and Gustafsson JÅ:
Estrogen receptors in breast carcinogenesis and endocrine therapy.
Mol Cell Endocrinol. 418(Pt 3): 1–244. 2015.PubMed/NCBI
|
7
|
Li G, Zhang J, Jin K, He K, Zheng Y, Xu X,
Wang H, Wang H, Li Z, Yu X, et al: Estrogen receptor-α36 is
involved in development of acquired tamoxifen resistance via
regulating the growth status switch in breast cancer cells. Mol
Oncol. 7:611–624. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Penot G, Le Péron C, Mérot Y,
Grimaud-Fanouillère E, Ferrière F, Boujrad N, Kah O, Saligaut C,
Ducouret B, Métivier R and Flouriot G: The human estrogen
receptor-alpha isoform hERalpha46 antagonizes the proliferative
influence of hERalpha66 in MCF7 breast cancer cells. Endocrinology.
146:5474–5484. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Harris L, Fritsche H, Mennel R, Norton L,
Ravdin P, Taube S, Somerfield MR, Hayes DF and Bast RC Jr; American
Society of Clinical Oncology, : American Society of Clinical
Oncology 2007 update of recommendations for the use of tumor
markers in breast cancer. J Clin Oncol. 25:5287–5312. 2007.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Singletary SE, Allred C, Ashley P, Bassett
LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, et
al: Revision of the american joint committee on cancer staging
system for breast cancer. J Clin Oncol. 20:3628–3636. 2002.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Denger S, Reid G, Kos M, Flouriot G,
Parsch D, Brand H, Korach KS, Sonntag-Buck V and Gannon F: ERalpha
gene expression in human primary osteoblasts: Evidence for the
expression of two receptor proteins. Mol Endocrinol. 15:2064–2077.
2001. View Article : Google Scholar : PubMed/NCBI
|
12
|
Li L, Haynes MP and Bender JR: Plasma
membrane localization and function of the estrogen receptor alpha
variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA.
100:pp. 4807–4812. 2003; View Article : Google Scholar : PubMed/NCBI
|
13
|
Wang Z, Zhang X, Shen P, Loggie BW, Chang
Y and Deuel TF: Identification, cloning, and expression of human
estrogen receptor-alpha36, a novel variant of human estrogen
receptor-alpha66. Biochem Biophys Res Commun. 336:1023–1027. 2005.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Flouriot G, Brand H, Denger S, Metivier R,
Kos M, Reid G, Sonntag-Buck V and Gannon F: Identification of a new
isoform of the human estrogen receptor-alpha (hER-alpha) that is
encoded by distinct transcripts and that is able to repress
hER-alpha activation function 1. EMBO J. 19:4688–4700. 2000.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Márquez DC and Pietras RJ:
Membrane-associated binding sites for estrogen contribute to growth
regulation of human breast cancer cells. Oncogene. 20:5420–5430.
2001. View Article : Google Scholar : PubMed/NCBI
|
16
|
Parl FF, Schmidt BP, Dupont WD and Wagner
RK: Prognostic significance of estrogen receptor status in breast
cancer in relation to tumor stage, axillary node metastasis, and
histopathologic grading. Cancer. 54:2237–2242. 1984. View Article : Google Scholar : PubMed/NCBI
|